Cytotoxic role of methylglyoxal in rat retinal pericytes: Involvement of a nuclear factor-kappaB and inducible nitric oxide synthase pathway

Chemico-Biological Interactions

Volumn 188, Issue 1, 2010, Pages 86-93

  Kim, Junghyun ^a   Kim, Ohn Soon ^a   Kim, Chan Sik ^a   Kim, Nan Hee ^a   Kim, Jin Sook ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Apoptosis; Inducible nitric oxide synthase; Methylglyoxal; Nuclear factor kappaB; Rat retinal pericytes

Indexed keywords

CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; METHYLGLYOXAL; N6 (1 IMINOETHYL)LYSINE; PYRROLIDINE DITHIOCARBAMATE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL NUCLEUS; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INDUCTION; GLYCOLYSIS; INHIBITION KINETICS; NICK END LABELING; NONHUMAN; PERICYTE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RETINA BLOOD VESSEL; RETINA CELL; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; RETINA; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; IN SITU NICK-END LABELING; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PERICYTES; PYRUVALDEHYDE; RATS; RATS, SPRAGUE-DAWLEY; RETINA;

RATTUS;

EID: 77956174800     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.07.002     Document Type: Article

References (60)

1. Cunha-Vaz J., Bernardes R. Nonproliferative retinopathy in diabetes type 2. Initial stages and characterization of phenotypes. Prog. Retin. Eye Res. 2005, 24:355-377.
2. Roy S., Sato T., Paryani G., Kao R. Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes 2003, 52:1229-1234.
3. Phillips S.A., Thornalley P.J. The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Eur. J. Biochem. 1993, 212:101-105.
4. Thornalley P.J., Langborg A., Minhas H.S. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem. J. 1999, 344(Pt 1):109-116.
5. Brownlee M. Lilly Lecture 1993. Glycation and diabetic complications. Diabetes 1994, 43:836-841.
6. McLellan A.C., Thornalley P.J., Benn J., Sonksen P.H. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin. Sci. 1994, 87:21-29.
7. Beisswenger P.J., Howell S.K., O'Dell R.M., Wood M.E., Touchette A.D., Szwergold B.S. Alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. Diabetes Care 2001, 24:726-732.
8. Lapolla A., Flamini R., Dalla Vedova A., Senesi A., Reitano R., Fedele D., Basso E., Seraglia R., Traldi P. Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method. Clin. Chem. Lab. Med. 2003, 41:1166-1173.
9. Randell E.W., Vasdev S., Gill V. Measurement of methylglyoxal in rat tissues by electrospray ionization mass spectrometry and liquid chromatography. J. Pharmacol. Toxicol. Methods 2005, 51:153-157.
10. Zeng J., Davies M.J. Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins. Chem. Res. Toxicol. 2005, 18:1232-1241.
11. Fukunaga M., Miyata S., Liu B.F., Miyazaki H., Hirota Y., Higo S., Hamada Y., Ueyama S., Kasuga M. Methylglyoxal induces apoptosis through activation of p38 MAPK in rat Schwann cells. Biochem. Biophys. Res. Commun. 2004, 320:689-695.
12. Akhand A.A., Hossain K., Mitsui H., Kato M., Miyata T., Inagi R., Du J., Takeda K., Kawamoto Y., Suzuki H., Kurokawa K., Nakashima I. Glyoxal and methylglyoxal trigger distinct signals for map family kinases and caspase activation in human endothelial cells. Free Radic. Biol. Med. 2001, 31:20-30.
13. Huang W.J., Tung C.W., Ho C., Yang J.T., Chen M.L., Chang P.J., Lee P.H., Lin C.L., Wang J.Y. Ras activation modulates methylglyoxal-induced mesangial cell apoptosis through superoxide production. Ren. Fail. 2007, 29:911-921.
14. Kim J., Son J.W., Lee J.A., Oh Y.S., Shinn S.H. Methylglyoxal induces apoptosis mediated by reactive oxygen species in bovine retinal pericytes. J. Korean Med. Sci. 2004, 19:95-100.
15. Du J., Suzuki H., Nagase F., Akhand A.A., Ma X.Y., Yokoyama T., Miyata T., Nakashima I. Superoxide-mediated early oxidation and activation of ASK1 are important for initiating methylglyoxal-induced apoptosis process. Free Radic. Biol. Med. 2001, 31:469-478.
16. Amicarelli F., Colafarina S., Cattani F., Cimini A., Di Ilio C., Ceru M.P., Miranda M. Scavenging system efficiency is crucial for cell resistance to ROS-mediated methylglyoxal injury. Free Radic. Biol. Med. 2003, 35:856-871.
17. Liu B.F., Miyata S., Hirota Y., Higo S., Miyazaki H., Fukunaga M., Hamada Y., Ueyama S., Muramoto O., Uriuhara A., Kasuga M. Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells. Kidney Int. 2003, 63:947-957.
18. Chan W.H., Wu H.J., Shiao N.H. Apoptotic signaling in methylglyoxal-treated human osteoblasts involves oxidative stress, c-Jun N-terminal kinase, caspase-3, and p21-activated kinase 2. J. Cell. Biochem. 2007, 100:1056-1069.
19. Cantero A.V., Portero-Otin M., Ayala V., Auge N., Sanson M., Elbaz M., Thiers J.C., Pamplona R., Salvayre R., Negre-Salvayre A. Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor-beta: implications for diabetic atherosclerosis. FASEB J. 2007, 21:3096-3106.
20. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43:109-142.
21. Yun H.Y., Dawson V.L., Dawson T.M. Nitric oxide in health and disease of the nervous system. Mol. Psychiatry 1997, 2:300-310.
22. Nathan C., Xie Q.W. Nitric oxide synthases: roles, tolls, and controls. Cell 1994, 78:915-918.
23. Abu El-Asrar A.M, Desmet S., Meersschaert A., Dralands L., Missotten L., Geboes K. Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am. J. Ophthalmol. 2001, 132:551-556.
24. Carmo A., Cunha-Vaz J.G., Carvalho A.P., Lopes M.C. Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability. Nitric Oxide 2000, 4:590-596.
25. Du Y., Smith M.A., Miller C.M., Kern T.S. Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J. Neurochem. 2002, 80:771-779.
26. Ellis E.A., Guberski D.L., Hutson B., Grant M.B. Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. Nitric Oxide 2002, 6:295-304.
27. Zheng L, Du Y., Miller C., Gubitosi-Klug R.A., Ball S., Berkowitz B.A., Kern T.S. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 2007, 50:1987-1996.
28. Romeo G., Liu W.H., Asnaghi V., Kern T.S., Lorenzi M. Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 2002, 51:2241-2248.
29. Kowluru R.A., Koppolu P., Chakrabarti S., Chen S. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic. Res. 2003, 37:1169-1180.
30. Zhang H., Chen X., Teng X., Snead C., Catravas J.D. Molecular cloning and analysis of the rat inducible nitric oxide synthase gene promoter in aortic smooth muscle cells. Biochem. Pharmacol. 1998, 55:1873-1880.
31. Lowenstein C.J., Alley E.W., Raval P., Snowman A.M., Snyder S.H., Russell S.W., Murphy W.J. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:9730-9734.
32. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 1994, 269:4705-4708.
33. Beck K.F., Sterzel R.B. Cloning and sequencing of the proximal promoter of the rat iNOS gene: activation of NFkappaB is not sufficient for transcription of the iNOS gene in rat mesangial cells. FEBS Lett. 1996, 394:263-267.
34. de Vera M.E., Shapiro R.A., Nussler A.K., Mudgett J.S., Simmons R.L., Morris S.M., Billiar T.R., Geller D.A. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:1054-1059.
35. Cai J., Kehoe O., Smith G.M., Hykin P., Boulton M.E. The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2008, 49:2163-2171.
36. Capetandes A., Gerritsen M.E. Simplified methods for consistent and selective culture of bovine retinal endothelial cells and pericytes. Invest. Ophthalmol. Vis. Sci. 1990, 31:1738-1744.
37. Kondo T., Hosoya K., Hori S., Tomi M., Ohtsuki S., Takanaga H., Nakashima E., Iizasa H., Asashima T., Ueda M., Obinata M., Terasaki T. Establishment of conditionally immortalized rat retinal pericyte cell lines (TR-rPCT) and their application in a co-culture system using retinal capillary endothelial cell line (TR-iBRB2). Cell Struct. Funct. 2003, 28:145-153.
38. Wang Y.L., Hui Y.N., Guo B., Ma J.X. Strengthening tight junctions of retinal microvascular endothelial cells by pericytes under normoxia and hypoxia involving angiopoietin-1 signal way. Eye 2007, 21:1501-1510.
39. Cacicedo J.M., Benjachareowong S., Chou E., Ruderman N.B., Ido Y. Palmitate-induced apoptosis in cultured bovine retinal pericytes: roles of NAD(P)H oxidase, oxidant stress, and ceramide. Diabetes 2005, 54:1838-1845.
40. Berkowitz B.A., Lukaszew R.A., Mullins C.M., Penn J.S. Impaired hyaloidal circulation function and uncoordinated ocular growth patterns in experimental retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 1998, 39:391-396.
41. Kim O.S., Kim J., Kim C.S., Kim N.H., Kim J.S. KIOM-79 prevents methyglyoxal-induced retinal pericyte apoptosis in vitro and in vivo. J. Ethnopharmacol. 2010, 129:285-292.
42. Kaltschmidt C., Kaltschmidt B., Henkel T., Stockinger H., Baeuerle P.A. Selective recognition of the activated form of transcription factor NF-kappa B by a monoclonal antibody. Biol. Chem., Hoppe-Seyler 1995, 376:9-16.
43. Koga K., Yamagishi S., Okamoto T., Inagaki Y., Amano S., Takeuchi M., Makita Z. Serum levels of glucose-derived advanced glycation end products are associated with the severity of diabetic retinopathy in type 2 diabetic patients without renal dysfunction. Int. J. Clin. Pharmacol. Res. 2002, 22:13-17.
44. Miura J., Yamagishi S., Uchigata Y., Takeuchi M., Yamamoto H., Makita Z., Iwamoto Y. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes. J. Diabetes Complications 2003, 17:16-21.
45. Miller A.G., Smith D.G., Bhat M., Nagaraj R.H. Glyoxalase I is critical for human retinal capillary pericyte survival under hyperglycemic conditions. J. Biol. Chem. 2006, 281:11864-11871.
46. Lapolla A., Reitano R., Seraglia R., Sartore G., Ragazzi E., Traldi P. Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress. Mol. Nutr. Food Res. 2005, 49:685-690.
47. Brouwers O., Niessen P.M., Haenen G., Miyata T., Brownlee M., Stehouwer C.D., De Mey J.G., Schalkwijk C.G. Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia 2010, 53:989-1000.
48. Chaplen F.W., Fahl W.E., Cameron D.C. Evidence of high levels of methylglyoxal in cultured Chinese hamster ovary cells. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:5533-5538.
49. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998, 16:225-260.
50. Schreck R., Meier B., Mannel D.N., Droge W., Baeuerle P.A. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 1992, 175:1181-1194.
51. Bessho R., Matsubara K., Kubota M., Kuwakado K., Hirota H., Wakazono Y., Lin Y.W., Okuda A., Kawai M., Nishikomori R., et al. Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem. Pharmacol. 1994, 48:1883-1889.
52. Kim C.H, Kim J.H., Hsu C.Y., Ahn Y.S. Zinc is required in pyrrolidine dithiocarbamate inhibition of NF-kappaB activation. FEBS Lett. 1999, 449:28-32.
53. Becquet F., Courtois Y., Goureau O. Nitric oxide in the eye: multifaceted roles and diverse outcomes. Surv. Ophthalmol. 1997, 42:71-82.
54. Inomata M., Hayashi M., Shumiya S., Kawashima S., Ito Y. Involvement of inducible nitric oxide synthase in cataract formation in Shumiya cataract rat (SCR). Curr. Eye Res. 2001, 23:307-311.
55. Ito Y., Nabekura T., Takeda M., Nakao M., Terao M., Hori R., Tomohiro M. Nitric oxide participates in cataract development in selenite-treated rats. Curr. Eye Res. 2001, 22:215-220.
56. Chiou G.C. Review: effects of nitric oxide on eye diseases and their treatment. J. Ocul. Pharmacol. Ther. 2001, 17:189-198.
57. Tsai D.C., Chiou S.H., Lee F.L., Chou C.K., Chen S.J., Peng C.H., Kuo Y.H., Chen C.F., Ho L.L., Hsu W.M. Possible involvement of nitric oxide in the progression of diabetic retinopathy. Ophthalmologica 2003, 217:342-346.
58. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:1620-1624.
59. Ischiropoulos H., Al-Mehdi A.B. Peroxynitrite-mediated oxidative protein modifications. FEBS Lett. 1995, 364:279-282.
60. Li J., Su J., Li W., Liu W., Altura B.T., Altura B.M. Peroxynitrite induces apoptosis in canine cerebral vascular muscle cells: possible relation to neurodegenerative diseases and strokes. Neurosci. Lett. 2003, 350:173-177.